The decline in gold and silver was fast and sharp as panic selling set in, resulting in major technical damage. Currently, gold is technically bearish and it could fall further.
We recently recommended lowering your metals position from 30% to 15% of your total portfolio, and we maintain that recommendation.
Lower your positions in the shares and ETFs like SPDR Gold Trust (GLD), iShares Gold Trust (IAU) and iShares Silver Trust (SLV). Keep the proceeds in U.S. dollars for the time being.
Primarily keep your physical gold and silver core positions; that is, coins and bullion you plan to keep over the long haul, riding through periods of weakness.
Best Freight Stocks To Own Right Now: Spectral Diagnostics Inc (DIAGF)
Spectral Diagnostics Inc. (Spectral), incorporated on July 29, 1991, focuses on the development and commercialization, in North America, treatment for severe sepsis and septic shock. The Company also manufactures and sells certain reagents. Its products include Rapid Diagnostics for Sepsis, Endotoxin Activity Assay (EAA) and Toraymyxin. As of December 31, 2011, Spectral�� EAA endotoxin measurement was the only the United Sates Food and Drug Administration (FDA) cleared diagnostic on the market. Spectral Diagnostics (US) Inc. and Spectral Diagnostics (New Brunswick) Inc. are its subsidiaries.
The Company has developed a rapid diagnostic test for detection of components of gram negative bacterial cell wall (endotoxin). The EAA instrument is manufactured under contract for use in the hospital setting. The Toraymyxin hemoperfusion device removes endotoxin from the bloodstream and is manufactured by Toray Industries Inc. of Japan. The product is sold in Japan and Europe and has been used over 80,000 patients worldwide. As of December 31, 2011, Spectral was conducting clinical trials for the purpose of seeking regulatory approval in the United States. Spectral develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies. Royalty revenues are earned from these license arrangements based on a percentage of end user sales of Troponin I.
The Company competes with Eli Lilly, Agennix AG, AstraZeneca, Eisai, Gambro, InflammaGen Therapeutics, Fresenius and CytoSorbents.
Advisors' Opinion:- [By maarnio]
Spectral Diagnostics (DIAGF) develops and commercializes theranostic treatment for severe sepsis in North America.
Shares outstanding (March 31, 2014)
Best Heal Care Stocks To Watch For 2014: Toro Co (TTC)
The Toro Company (Toro), incorporated on November 7, 1983, designs, manufactures, and markets professional turf maintenance equipment and services, turf irrigation systems, agricultural micro-irrigation systems, landscaping equipment and lighting, and residential yard and snow removal products. The Company operates in three business segments: Professional, Residential, and Distribution. Its products are advertised and sold at the retail level under the names of Toro, Exmark, Irritrol, Hayter, Pope, Lawn-Boy and Lawn Genie. In October 2013, the Company acquired Xiamen Xiangfeng Water Saving Equipment Co., Ltd.
Professional
The Company designs professional turf, landscape, and agricultural products and markets them worldwide through a network of distributors and dealers, as well as directly to Government customers, rental companies, and retailers. These channel partners then sell its products to professional users engaged in creating and renovating landscapes, irrigating turf and agricultural fields, and maintaining turf, such as golf courses, sports fields, municipal properties, and residential and commercial landscapes.
Landscape Contractor Market
The Company market products to landscape contractors under the Toro and Exmark brands. Products for the landscape contractor market include zero-turn radius riding mowers, heavy-duty walk behind mowers, mid-size walk behind mowers, stand-on mowers, and turf renovation and tree care equipment. It also offers some products with electronic fuel injection engine options. In fiscal 2013, it enhanced its line of Toro Z Master Commercial 3000 Series mowers, featuring its TURBO FORCE cutting deck, integrated pump, and wheel motors designed for professional results, performance, and dependability. In addition, in fiscal 2013, it introduced the new Exmark Vantage X-Series stand-on mower.
Sports Fields and Grounds Market
Products for the sports fields and grounds market include riding rotar! y mowers and attachments, aerators, and debris management products, which include versatile debris vacuums, blowers, and sweepers. Other products include multipurpose vehicles, such as the Toro Workman, that can be used for turf maintenance, towing, and industrial hauling. These products are sold through distributors, who then sell to owners and/or managers of sports fields, Governmental properties, and residential and commercial landscapes.
Golf Course Market
The Company�� products for the golf course market include large reel and rotary riding products for fairway, rough and trim cutting; riding and walking mowers for putting greens and specialty areas; greens rollers; turf sprayer equipment; utility vehicles; aeration equipment; and bunker maintenance equipment. In fiscal 2013, it introduced the Reelmaster 3550-D, which features a productive 82 inch cutting width, enhanced ground-following capability with turf-friendly tires, and three-wheel drive system designed for traction in hilly and wet conditions. In addition, in fiscal 2013, it began offering versions of its golf products which are compliant with Tier 4 diesel engine emission requirements. It also manufacture and market underground irrigation systems for the golf course market, including sprinkler heads, controllers, turf sensors, and electric, battery-operated, and hydraulic valves. Its 835S/855S Series golf sprinklers are equipped with a unique TruJectory feature that provides enhanced water distribution control. Its Turf Guard wireless soil monitoring systems are designed to measure soil moisture, salinity, and temperature through buried wireless sensors that communicate through an Internet server for processing and presentation to a user through the Web.
Residential/Commercial Irrigation and Lighting Market
Turf irrigation products marketed under the Toro and Irritrol brands include rotors; sprinkler bodies and nozzles; plastic and brass valves; drip tubing and subsurface irrigation; ! electric ! and hydraulic control devices; and wired and wireless rain, freeze, and climate sensors. These products are designed to be used in residential and commercial turf irrigation systems that are installed into new systems or used to replace or retrofit existing systems. Most of the product lines are designed for underground automatic irrigation. Electric and hydraulic controllers activate valves and sprinkler bodies and nozzles in a typical irrigation system. Its retail irrigation products are marketed under the Toro and Lawn Genie brand names. These products are designed for homeowner installation and include sprinkler heads, valves, timers, and drip irrigation systems. Its ECXTRA sprinkler timers can be used with a home computer and its Scheduling Advisor recommends the proper watering schedule based on the local weather, plant type, and sprinkler. It manufactures and market lighting products under the Unique Lighting Systems brand name.
Micro-Irrigation Market
Products for the micro-irrigation market include products that regulate the flow of water for drip irrigation, including Aqua-Traxx PBX drip tape, Aqua-Traxx PC (pressure-compensating) drip tape, Blue Stripe polyethylene tubing, BlueLine drip line, and NGE emitters, all used in agriculture, mining, and landscape applications. In addition to these products, it offers control devices and connection options. These products are sold primarily through dealers and distributors who then sell to end users for use primarily in vegetable fields, fruit and nut orchards, vineyards, landscapes, and mines. In fiscal 2013, it expanded its product offering of the Neptune thinwall dripline into the North America market, featuring a medium-durability dripline that enables growers to install a subsurface drip irrigation system designed to last for up to ten years and to allow growers of medium-length crops to adopt drip irrigation. In addition, in fiscal 2013, it introduced AquaFlow 3.2 Drip Irrigation Design Software, a new software packag! e used to! help design drip irrigation systems.
Rental and Construction Market
The Company offers over 35 attachments for our compact utility loaders, including trenchers, augers, vibratory plows, and backhoes. In fiscal 2013, it launched the STX-38 Stump Grinder featuring high maneuverability and hydraulic sweep control. Products for the rental market include compact utility loaders, walk-behind trenchers, stump grinders, and turf renovation products, many of which are also sold to landscape contractors. Its presence in the construction market is driven by an equipment line of vibratory plows, trenchers, and horizontal directional drills, all of which are used in the installation, repair, and replacement of underground utilities with minimal impact on surrounding landscapes or structures. In fiscal 2013, it introduced the Toro Pro Sneak Vibratory Plow that delivers consistent and powerful plowing in a compact, maneuverable package.
Residential
The Company markets its residential products to homeowners through a variety of distribution channels, including outdoor power equipment dealers, hardware retailers, home centers, mass retailers, and over the Internet. These products are sold mainly in North America, Europe, and Australia, with the exception of snow removal products that are sold primarily in North America and Europe.
Walk Power Mower Products
The Company manufactures and markets a number of walk power mower models under its Toro and Lawn-Boy brand names, as well as the Pope brand in Australia and the Hayter brand in the United Kingdom. Toro also offers a line of rear-roller walk power mowers, a design that provides a striped finish, for the United Kingdom market.
Riding Products
The Company manufactures and markets riding products under the Toro brand name worldwide and under the Hayter brand name in the United Kingdom. Riding products primarily consist of zero-turn radius mowers. Lawn and garden tra! ctor mode! ls are sold worldwide. In addition, its rear engine and direct-collect riding mowers are manufactured and sold in the European market. A number of models are available with a variety of engines, decks, transmissions, and accessories.
Home Solutions Products
Toro designs and markets home solutions products under the Toro and Pope brand names, including electric and battery-operated grass trimmers, electric blower-vacuums, electric blowers, and electric snow throwers. In Australia, the Company also designs and markets underground and hose-end retail irrigation products under the Pope brand name.
Gas Snow Removal Products
The Company manufactures and markets a range of gas-powered single-stage and two-stage snow thrower models. Single-stage snow throwers are walk behind units with lightweight two- and four-cycle gasoline engines. Its two-stage snow throwers are designed for large areas of deep, heavy snow and use four-cycle engines. The Company�� two-stage snow throwers include a line of models featuring the Power Max auger system and the Quick Stick chute control technology.
Advisors' Opinion:- [By Ben Levisohn]
Still, shares of Deere have gained 0.2% to $86.08, perhaps thanks to Toro (TTC), which has risen 1.8% to $62.34 after beating earnings forecasts by four cents today.
- [By Rich Duprey]
Consumer landscape equipment maker�Toro� (NYSE: TTC ) �announced yesterday its second-quarter dividend of $0.14 per share, the same rate it paid the past two quarters after raising the payout 27% from $0.11 per share.
- [By Charles Sizemore]
Stuart Varney took it a step further, mentioning Toro Company (TTC), the maker of many of the snow blowers that have become a common sight across much of America this year. I agreed, adding that Toro is a major manufacturer of lawn and turf maintenance equipment — and because virtually every lawn, park and golf course in America has suffered damage this year, and Toro is well positioned to profit from the repairs.
- [By Ben Levisohn]
Shares of Deere have dropped 0.7% to $93.65 at 3:49 p.m. today, while Agco (AGCO) has dipped 0.1% to $55.12, Toro (TTC) has gained 1% to $65.17 and Caterpillar (CAT) has risen 1.2% to $106.27.
Best Heal Care Stocks To Watch For 2014: Redrow PLC (RDW)
Redrow PLC is a United Kingdom-based company engaged in residential development, which includes mixed use development. The Company�� operations are primarily focused on house building. Its completed projects include Signature, In the City/Regeneration and Debut. The Company's land holdings consist of both a current and forward land bank. As of June 30, 2010, the current land bank consisted of 11,600 plots owned with planning and 1,570 contracted plots, and its forward lank bank stood at around 22,000 plots. Its subsidiaries include Redrow Homes (Scotland) Ltd, Redrow Homes (Yorkshire) Ltd, Redrow Homes (Lancashire) Ltd, Redrow plc & Redrow Homes (NW) Ltd, Redrow Homes (Midlands) Ltd, Redrow Homes (South Midlands) Ltd, Redrow Homes (South West) Ltd, Redrow Homes (South Wales) Ltd and Redrow Homes (Eastern) Ltd. Advisors' Opinion:- [By Namitha Jagadeesh]
Redrow Plc (RDW) rallied 3.2 percent to 245.6 pence as Deutsche Bank AG increased its 12-month share-price estimate and profit forecasts for 2013 and 2014. The U.K. builder yesterday jumped the most in five months after saying pretax profit for the year ended June will beat analysts��estimates.
Best Heal Care Stocks To Watch For 2014: VASCO Data Security International Inc. (VDSI)
VASCO Data Security International, Inc., through its subsidiaries, engages in the design, development, marketing, and support of hardware and software security systems that manage and secure access to information assets worldwide. The company offers hardware and software products in the areas of user authentication, electronic signatures, and digital signatures/public key infrastructure. It provides VACMAN Controller that supports multiple authentication technologies, including passwords, dynamic password technology, electronic signatures, digital signatures, and certificates and biometrics on one platform. The company also offers IDENTIKEY Server, a centralized authentication server that supports the deployment, use, and administration of DIGIPASS user authentication. In addition, it provides aXs GUARD Identifier, a standalone authentication solution, which offers two-factor authentication for remote access to a corporate network or to Web-based in-house business applicat ions; and aXs GUARD Gatekeeper that integrates DIGIPASS to provide secure two factor user authentication. Further, the company offers DIGIPASS product line exists as a family of software and hardware client authentication products and services for authenticating users to any network, including the Internet. Its DIGIPASS solution calculates dynamic signatures and passwords to authenticate users on a computer network and for various other applications. The DIGIPASS technology is also designed to operate on desktop personal computers or laptops, personal digital assistants, mobile phones, and smart cards. VASCO sells its security solutions through its direct sales force, as well as through distributors, resellers, and systems integrators. The company was founded in 1996 and is headquartered in Oakbrook Terrace, Illinois.
Advisors' Opinion:- [By Garrett Cook]
Shares of VASCO Data Security International (NASDAQ: VDSI)got a boost,shooting up 25.26 percent to $22.91 after the company posted a profit in the third quarter.
- [By Garrett Cook]
Shares of VASCO Data Security International (NASDAQ: VDSI) got a boost, shooting up 28.62 percent to $23.53 after the company posted a profit in the third quarter.
Best Heal Care Stocks To Watch For 2014: ImmunoGen Inc.(IMGN)
ImmunoGen, Inc. engages in the research and development of targeted therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies, and highly potent cell-killing agents. The company develops its products using its Targeted Antibody Payload (TAP) technology. Its product candidates include Trastuzumab emtansine (T-DM1), a Phase III clinical trial product for HER2+ breast cancer; lorvotuzumab mertansine (IMGN901), a Phase I clinical trial product, which targets CD56 found on small-cell lung cancer, Merkel cell carcinoma, multiple myeloma, ovarian cancers, carcinoid tumors, and other cancers of neuroendocrine origin; IMGN529, a pre-investigational new drug stage drug for CD37+ B-cell malignancies, such as non-Hodgkin's lymphoma; and IMGN853, a preclinical stage product for cancers that overexpress folate receptor 1, including ovarian cancer. The company?s earlier-stage compounds in development stage comprise SAR3419, a Phase I clinical trial product for CD19+ B-cell malignancies, including non-Hodgkin's lymphoma; SAR650984, a Phase I clinical trial product for CD38+ hematological malignancies; SAR566658, a phase one clinical trial product for DS6+ solid tumors; and BT-062, a Phase I product for multiple myeloma. It has collaboration agreements with Amgen, Inc.; Bayer Schering Pharma AG; Biogen Idec MA Inc.; Biotest AG; Genentech, Inc.; Novartis Institutes for BioMedical Research, Inc.; and sanofi-aventis U.S. LLC. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
High-risk, high-reward suggestions
Exelixis (NASDAQ: EXEL ) : In November Exelixis had its first drug, known as Cometriq, approved by the Food and Drug Administration to treat metastatic medullary thyroid cancer. Although the market for this disease is pretty small -- somewhere between 500 and 700 people in the U.S. -- the near-tripling in progression-free survival, or PFS, in trials would indicate to me a strong likelihood that it could translate to success in other cancer types. In mid-stage prostate cancer trials, for instance, Cometriq was found to be particularly effective in dealing with bone metastases as a second or third-line treatment. We won't get any additional data until next year on Cometriq, but positive data on the prostate cancer front could be enough to double its share price if the PFS, compared to the placebo, is notably strong. ImmunoGen (NASDAQ: IMGN ) : In February, Roche�and ImmunoGen received approval for Kadcyla as a secondary treatment for HER2-positive breast cancer. This is ImmunoGen's first drug approval, and it gives the company a chance to showcase what I feel is one of the future pathways of fighting cancer -- its targeted-antibody payload, or TAP, technology. ImmunoGen's TAP technology works by attaching a toxin -- in this case Roche's Herceptin -- to an antibody, and teaching that antibody to release the to
There's an undeniably large dollar amount being pledged to cancer research, but, even if a drug gains approval, that's no guarantee that the biotech or pharmaceutical company behind that drug will be a success. Some of the biggest gains (and losses) come from taking a leap of faith based on clinical data, or the approval of one or two drugs or devices within a pipeline. After that, it's all up to the drug or devices' effectiveness, its pricing, and the success of the marketing teams promoting the drug or device. Here are a few high-risk, high-reward names you should be keeping your eye on. - [By Sean Williams]
Now what: We're still in the top of the second inning of a nine-inning game here, but ADCs certainly appear to be the future of cancer therapy -- at least one path to treating it. Immunomedics still has a long road to climb as its two ADC peers are much further along in their development process. ImmunoGen (NASDAQ: IMGN ) , for instance, already has an FDA-approved drug for late-stage HER2-positive breast cancer known as Kadcyla that utilizes the company's proprietary targeted-antibody payload technology (the same concept as ADCs with a different name) in combination with Roche's�Herceptin. In trials, this combo extended median overall survival by 5.8 months over the placebo to 30.9 months. Something similar can be said for Seattle Genetics�and its ADC pipeline.
Best Heal Care Stocks To Watch For 2014: Stepan Co (SCL)
Stepan Company, incorporated on February 19, 1959, produces specialty and intermediate chemicals, which are sold to other manufacturers and then made into a variety of end products. The Company serves principal markets, such as manufacturers of cleaning and washing compounds (including detergents, shampoos, fabric softeners, toothpastes and household cleaners), paints, cosmetics, food and beverages, agricultural products, plastics, furniture, automotive equipment, insulation and refrigeration. The Company has three segments: surfactants, polymers and specialty products. The Company operates in the geographical regions of North America, Europe, Latin America and Asia. As of December 31, 2012, the Surfactants segment accounted to 72%, Polymers segment accounted to 24% and Specialty segment accounted to 4% of the Company�� revenues. On March 22, 2012, the Company increased its controlling interest in Stepan Philippines Inc from 89% to 100%.
Surfactants
Surfactants are used in a variety of consumer and industrial cleaning compounds as well as in agricultural products, lubricating ingredients, biodiesel and other specialized applications. The Surfactants are principal ingredients in consumer and industrial cleaning products, such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Surfactants are manufactured at six North American sites (five in the United States and one in Canada), three European sites (United Kingdom, France and Germany), and three Latin American sites (Mexico, Brazil and Colombia), and one Asian site (Philippines and Singapore). The Company also holds a 50% ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields.
Polymers
Polymers generate its revenues primarily from the sale of polyols and phthalic anhydride used in plastics, buildi! ng materials and refrigeration systems. It includes two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of rigid laminate insulation board for thermal insulation in the construction industry. Polyols are also a base raw material for flexible foams, coatings, adhesives, sealants and elastomers.
Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, phthalic anhydride is used internally in the production of polyols. In the United States, polymer product lines are manufactured at the Company�� Millsdale, Illinois, site. In Europe, polyols are manufactured at the Company�� subsidiaries in Germany and Poland. In Asia, polyols are produced at the Company�� 80% owned joint venture in Nanjing, China.
Specialty Products
Specialty products are used in food, flavoring and pharmaceutical applications. It includes flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are primarily manufactured at the Company�� Maywood, New Jersey, site.
Advisors' Opinion:- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Stepan (NYSE: SCL ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Stepan doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue decreased 4.8%, and inventory increased 30.6%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue dropped 1.9%, and inventory grew 30.6%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 6.9%, and inventory grew 9.5%. - [By Monica Gerson]
Stepan Company (NYSE: SCL) is expected to report its Q3 earnings at $0.93 per share on revenue of $467.40 million.
Lennox International (NYSE: LII) is projected to report its Q3 earnings at $1.28 per share on revenue of $877.87 million.
No comments:
Post a Comment